Clinical Trial Update: Study to Compare Exposure of TA Following Administration of FX006 or TAcs in Patients With OA of the Shoulder or Hip [Phase 2]

View source ↗

Summary

Phase 2 trial comparing exposure of FX006 and TAcs in patients with osteoarthritis of the shoulder or hip has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Hip
• Osteoarthritis of the Shoulder

Drugs mentioned

• FX006
• tACS

Snippet

Sponsor: Pacira Pharmaceuticals, Inc | Conditions: Osteoarthritis of the Shoulder, Osteoarthritis of the Hip | Phase 2 | Status: COMPLETED | Results posted: 2019-12-09